About
Bill Young joined NanoString as Executive Chairman after serving from 1999 to 2009 as Chairman and Chief Executive Officer of Monogram Biosciences, Inc., a pioneer in the field of personalized medicine. From 1997 to 1999, William Young served as Chief Operating Officer of Genentech, Inc. William Youngjoined Genentech in 1980 as Director of Manufacturing and Process Sciences and became Vice President in 1983. Prior to joining Genentech, William Young was with Eli Lilly & Co. for 14 years. William Young currently serves as the Chairman of the Board of Biogen Idec, Inc., is a Director and Chairman Emeritus for BayBio, and is a Director at Theravance, Inc. William Young holds a B.S. in Chemical Engineering from Purdue University and a M.B.A. from Indiana University and an Honorary Doctorate in Engineering from Purdue University.
Position in the VCSift Database
- • 5 investors at Clarus Ventures are tracked.
- • 421 investors hold the Venture Partner role in VCSift. William Young is one of them.
- • 7,285 investors are based in San Francisco, California, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- San Francisco, US
Contact Information
Find more investors like William
Search Investors